FDA approves first precision medicine for the treatment of cancers with certain genetic defects, including prostate cancer
On May 23, 2017, the field of precision medicine achieved a major milestone with the FDA’s first ever approval of a cancer therapy based entirely on a tumor’s unique characteristics...Read More
Prostate cancer cells that commit identify fraud
A new study reported at the 2017 American Association for Cancer Research (AACR) Annual Meeting identified new mechanisms and treatment approach for an aggressive subtype of AR-therapy resistant prostate cancer....Read More
“Get checked under the hood. Be a responsible grown-up.”
So, you’re 42. You’re into health and fitness, and fairly attuned to your body: you know something’s not right with your urinary tract, and you go to the doctor to...Read More
Joe Torre Prostate Cancer Foundation PSA (30sec)
Joe Torre Prostate Cancer Foundation PSA (30sec) https://vimeo.com/737335277/0152a8ec4a Read More
2017 Prostate Cancer Survey
At PCF, we proudly work every day to advance world-class research in an effort to prevent and, eventually, eradicate prostate cancer. We firmly believe that fostering an open and inclusive...Read More
Many vs Cancer, the First Major Global Crowdfunding Initiative to Defeat Prostate Cancer, Launches Today
LOS ANGELES, May 17, 2017 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the launch of Many vs Cancer (MvC), its first global fundraising initiative that is harnessing the...Read More
Study finds genetic difference in prostate cancer in African-Americans
Dana-Farber Cancer Institute News Release May 17,2017 The genomic discovery may partly explain why prostate cancer is more aggressive in black men Scientists say more blacks and other under-represented groups...Read More
Will Your Cancer Respond to Hormone Therapy?
Hormone therapy is a standard treatment for metastatic prostate cancer patients but may also benefit a subset of localized prostate cancer patients who underwent surgery but have particularly aggressive disease....Read More
Scientists Identify Biomarkers to Guide Hormone Therapy for Prostate Cancer
University of California San Francisco News Release May 11, 2017 A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will...Read More
Advanced Prostate Cancer Treatment Failure Due to Cell Reprogramming
New York, NY (May 4, 2017)—Columbia University Medical Center (CUMC) researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to...Read More
- 1
- 2